AIBN is solving serious problems in health, energy and the bioeconomy
using advanced biomanufacturing, precision nanomedicine and nanoengineered materials.
Our research teams are working with industry and governments to make critical strides forward and impacts in areas that include: mRNA manufacturing and vaccine development, diagnostics to discover and treat diseases, future foods and biosustainability projects reprograming cells to help the world’s biggest companies transition to net zero.
The AIBN at a glance
Part of Australia's
#1 University500+ world-class researchers
9 co-located NCRIS Facilities
Over $250m in research revenue
100+ industry partnerships
22% of UQ’s patent portfolio is generated by the AIBN
Our impact
- Partnering with LanzaTech to convert waste gases into valuable products, helping reduce reliance on fossil fuels and combat climate change
- Indigenous knowledge and advanced materials research shaping a shared future
- Reimagining global vaccine delivery with a needle-free patch no bigger than a postage stamp
Latest News
-
-
The cancer drug with a secret signal
14 October 2026
Partner with us
Contact us and learn how our scientific expertise and cutting edge facilities could help you reach your goals.


